Literature DB >> 15623422

Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt.

Takashi Matsui1, Anthony Rosenzweig.   

Abstract

Effective cardioprotection in clinical settings requires not only cardiomyocyte survival but also preservation of function. Multiple growth factors protect the heart from ischemic and other injury. While the downstream signaling pathways of these cardioprotective factors are complex, activation of phosphoinositide 3-kinase (PI 3-kinase) and its downstream effector, the serine-threonine kinase Akt (or Protein Kinase B), is a common feature in many cases. Genetic manipulations in cardiomyocytes both in vitro and in vivo suggest that acute activation of this pathway can promote both cardiomyocyte survival and function. Here, we review PI 3-kinase and Akt signaling, with a focus on their role in cardiomyocyte growth, survival, and function. Finally, the clinical implications of these studies will be considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623422     DOI: 10.1016/j.yjmcc.2004.11.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  85 in total

1.  Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells.

Authors:  D Lin; G Li; Z Zuo
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

2.  β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.

Authors:  Giovanni Fajardo; Mingming Zhao; Gerald Berry; Lee-Jun Wong; Daria Mochly-Rosen; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2011-07-02       Impact factor: 5.000

3.  Altered expression of the natriuretic peptide system in genetically modified heme oxygenase-1 mice treated with high dietary salt.

Authors:  David W J Armstrong; M Yat Tse; Luis G Melo; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2010-09-25       Impact factor: 3.396

Review 4.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

5.  Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies.

Authors:  Anand P Singh; Michael S Glennon; Prachi Umbarkar; Manisha Gupte; Cristi L Galindo; Qinkun Zhang; Thomas Force; Jason R Becker; Hind Lal
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

6.  Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway.

Authors:  Dinender K Singla; Reetu D Singla; Debbie E McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

7.  Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes.

Authors:  Tatsuma Okazaki; Satoru Ebihara; Masanori Asada; Shinsuke Yamanda; Yoshifumi Saijo; Yasuyuki Shiraishi; Takae Ebihara; Kaijun Niu; He Mei; Hiroyuki Arai; Tomoyuki Yambe
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

8.  Prolonged leptin treatment increases transient outward K⁺ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes.

Authors:  Nieves Gómez-Hurtado; María Fernández-Velasco; María Soledad Fernández-Alfonso; Lisardo Boscá; Carmen Delgado
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

9.  Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock.

Authors:  David J Durgan; Thomas Pulinilkunnil; Carolina Villegas-Montoya; Merissa E Garvey; Nikolaos G Frangogiannis; Lloyd H Michael; Chi-Wing Chow; Jason R B Dyck; Martin E Young
Journal:  Circ Res       Date:  2009-12-10       Impact factor: 17.367

Review 10.  Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.

Authors:  Kaie Ojamaa
Journal:  Vascul Pharmacol       Date:  2009-12-11       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.